Zeitschriftenartikel: „Constipation“

1

Talley, Nicholas J. „Managing Chronic Constipation From Constipating Medicines“. Southern Medical Journal 100, Nr. 11 (November 2007): 1070–71. http://dx.doi.org/10.1097/smj.0b013e318157ec3d.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Muawanah, Muawanah, und Triska Susila Nindya. „HUBUNGAN ASUPAN SERAT DAN CAIRAN DENGAN KEJADIAN KONSTIPASI PADA IBU PASCA MELAHIRKAN“. Media Gizi Indonesia 11, Nr. 1 (15.05.2017): 101. http://dx.doi.org/10.20473/mgi.v11i1.101-105.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Annotation:

Postpartum constipation with symptoms such as pain or discomfort, straining and hard stools is a common condition that affects the incidence of hemoroids and pain in the area of episiotomy. Constipation is associated with inadequate intake of fi ber and fl uid. This study aimed to analyze the relationship between intake of fiber, fluids and constipationin postpartum mother. The study design was observational with cross sectional approach on thirty three (33) post partum mothers using systemic random sampling method in April to May 2016. Data was analyzed by chi-square test. The result showed that 97% of postpartum mother had inadequate fi ber intake and only 3% were adequate. There was 9.1% postpartum mother with inadequate fluid intake and 90.9% were categorized as adequate. There was 54.5% of postpartum mother had constipation, while 45.5% not constipated. Based on chi-square test, there was no signifi cant relationship between fiber intake, fluid intake and constipation (p > 0.05). The conclusion that there was no relationshipin fiber intake, fluid intake with the incidence of constipation in postpartum mother. This requires provision of health education to prevent the occurance of constipation in postpartum mother.Keywords: fluid intake, fiber intake, constipation, postpartum

3

Sudnickaitė, Urtė, Brigita Aidukienė und Kazys Simanauskas. „Frequency, Causes, Diagnostics and Treatment of Constipation in Family Doctors Work“. Sveikatos mokslai 25, Nr. 2 (20.04.2015): 46–53. http://dx.doi.org/10.5200/sm-hs.2015.030.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Annotation:

Constipation is a highly prevalent disorder in the primary care. The observed morbidity differences between gender, age, socioeconomic classes with different feeding habits, physical activity and related diseases. Aim. To evaluate causes, diagnostic, treatment features of constipation in the primary care. Methods: was made random interviews of people between 20-80 years old. For interview was used questionnaire of KESS (The Knowles- Eccersley- Scott- Symptom scoring system) for the diagnostic of constipation and 13 questions to assess the risks. The pilot testing of questionnaire validity was carried out, the overall Cronbach alpha coefficient is 0.978. Statistical analysis was performed using Microsoft Office Excel 2007 and SPSS 13.0 for Windows data packets. Results. Was interviewed 320 people, of which 33.13% were established constipations. The average duration of constipation ranged from 18 month up 5 years. The average age of patients with constipation was 56±14.99 years and the healthy group- 41±14.20 years (p0,05). No differences were observed between man and women (p>0.05). Educational groups incidence of constipation was: high education – 29.19%, secondary – 30.3% and basic – 70.37%. We found, that most respondents eat irregularly, 3-4 times per day. We found, that increased fiber food usage, higher intake of fluid was correlated with lower incidence of constipation, as well as higher levels of physical activity or related chronic diseases (p 0.05). In assessing treatment, laxatives was used by 132 respondents, including 75.76% of patients with constipation and enemas was used by 53 respondents, including 94.43% of patients with constipation. Observed that only 62.26% of patients with constipation reported seeing a physician and 96.23% are treated independently. Conclusions: Purposefully interview of patients observed there is a high incidence of constipation. Differences of morbidity between genders are not observe, different than age and education groups. Not all investigated risk factors affect the incidence of constipation increased; mostly affects the small fluid, fiber food intake, physical activity and related chronic diseases. Patients are not give importance to this issue, and so thats why they do not seek a physician often and are treated independently.

4

Hida, Yuki, Teruhiko Imamura und Koichiro Kinugawa. „Constipation as a Drug-Related Adverse Effect in Patients with Hyperkalemia: Sodium Zirconium Cyclosilicate versus Conventional Potassium Binders“. Journal of Clinical Medicine 12, Nr. 18 (14.09.2023): 5971. http://dx.doi.org/10.3390/jcm12185971.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Annotation:

(1) Background: Constipation is one of the most serious adverse effects of potassium-lowering agents and decreases patients’ quality of life. Sodium zirconium cyclosilicate (SZC) is a recently innovated potassium binder intended for patients with hyperkalemia. The impact of SZC on the worsening of constipation, as compared with conventional potassium binders, remains unknown. (2) Methods: Patients with hyperkalemia who continued SZC for over 3 months between July 2020 and May 2022 were included in this retrospective study. Patients who received other conventional potassium binders during the same period were included as a control group. Trends in the doses of anti-constipation agents during the 3-month therapeutic period were compared between the two groups as a surrogate for worsening constipation. (3) Results: A total of 50 patients (median age 74 years, 31 male) were included, consisting of 22 patients with SZC and 28 patients with other conventional potassium binders. All patients had hyperkalemia and chronic kidney disease at baseline. During the 3-month therapeutic period, serum potassium levels decreased significantly in both groups (p < 0.05 for both). The number of anti-constipation remained unchanged in the SZC group but tended to increase in the control group (p = 0.56 and p = 0.090, respectively). The total dose change in all anti-constipations was significantly lower in the SZC group than in the control group (p = 0.037). (4) Conclusions: Conventional potassium binders have a tendency to worsen constipation, whereas SZC may have the potential to improve hyperkalemia without worsening constipation. SZC may be recommended, particularly in elderly patients with ongoing or high-risk constipation.

5

Ferrazzi, Simon, Grant W. Thompson, E. Jan Irvine, Pierre Pare und Laureen Rance. „Diagnosis of Constipation in Family Practice“. Canadian Journal of Gastroenterology 16, Nr. 3 (2002): 159–64. http://dx.doi.org/10.1155/2002/740413.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Annotation:

BACKGROUND: Patients who complain of constipation to their family doctor may not be truly constipated. Variability in stool frequency and consistency, and perception of symptoms may lead to inaccurate patient reporting or diagnosis of constipation.OBJECTIVES: To determine whether patients visiting their family doctor with a complaint of, or diagnosed with, constipation fulfilled the Rome II criteria for functional constipation and had stool characteristics of constipation.METHODS: A random sample of Canadian family physicians were recruited to enroll a series of adults who complained of, or had received a diagnosis of, constipation during an office visit. Patients were advised of the survey. Those providing written consent were contacted by an independent research firm and forwarded a survey questionnaire that included the Rome II gastrointestinal questionnaire, questions regarding their medical history and questions regarding their demographics. Patients also completed a four-week daily diary recording their bowel habits using the Bristol Stool Form Scale, medication use and satisfaction with treatment. Questionnaire and diary responses were retrieved by telephone.RESULTS: One hundred eighty-four family physicians enrolled 311 patients, of whom 220 completed the questionnaire. Females comprised 79.5% of the sample and had a mean age of 54.2 years (males 61.6 years; P<0.05). According to the Rome II criteria, 37.3% had functional constipation and 46.8% had irritable bowel syndrome (IBS). Whole gut transit times estimated using the Bristol Stool Scale were similar among those with self-reported constipation, those with Rome II functional constipation and those with Rome II IBS (79.3 h, 85.8 h and 77.4 h, respectively). Almost half of the patients with IBS or functional constipation were taking a pain medication, while nearly one-fifth took antidepressants. Of the medications or remedies taken to treat constipation, patients rated 49.8% of the doses as satisfactory.CONCLUSIONS: A large proportion of Canadian primary care patients whose presenting complaint or diagnosis was constipation satisfied the Rome II criteria for IBS, with a smaller number defined as functionally constipated. IBS patients tended to be younger than those with functional constipation, and whole gut transit times did not differentiate IBS from functional constipation. Careful questioning of patients who complain of constipation may reveal constipating medication, diarrhea symptoms or IBS.

6

Stewart, Sharon. „Constipation“. Nursing Standard 30, Nr. 31 (30.03.2016): 61–62. http://dx.doi.org/10.7748/ns.30.31.61.s47.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

LeLeiko, Neal S., Sarah Mayer-Brown, Carolina Cerezo und Wendy Plante. „Constipation“. Pediatrics in Review 41, Nr. 8 (31.07.2020): 379–92. http://dx.doi.org/10.1542/pir.2018-0334.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Winney, Jane. „Constipation“. Nursing Standard 13, Nr. 11 (02.12.1998): 49–56. http://dx.doi.org/10.7748/ns.13.11.49.s50.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Shafik, Ahmed. „Constipation“. Drugs 45, Nr. 4 (April 1993): 528–40. http://dx.doi.org/10.2165/00003495-199345040-00005.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

McShane, Ruth E., und Audrey M. McLane. „Constipation“. Nursing Clinics of North America 20, Nr. 4 (Dezember 1985): 801–8. http://dx.doi.org/10.1016/s0029-6465(22)01923-5.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

11

Shah, Brijen J., Nisha Rughwani und Suzanne Rose. „Constipation“. Annals of Internal Medicine 162, Nr. 7 (07.04.2015): ITC1. http://dx.doi.org/10.7326/aitc201504070.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

12

CHEN, DOOLEY, und BRADLEY SULLIVAN. „Constipation“. Pediatrics 77, Nr. 6 (01.06.1986): 933. http://dx.doi.org/10.1542/peds.77.6.933.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Annotation:

To the Editor.— Among the frequently encountered problems of a general or referral pediatrician are constipation and/or encopresis. We recently had a patient who presented with a chief complaint of increased stooling pattern, the cause of which may be an acceptable addition to the therapeutic modalities applied to constipated children. A 10-year-old boy, previously in good health, was brought in because his stool pattern had changed in the past 4 months. He was an individual who, prior to the change, went unnoticed as to his bowel habit.

13

Maffei, Helga Verena L., und Mauro B. Morais. „Constipation“. Jornal de Pediatria 76, Nr. 7 (15.07.2000): 147–56. http://dx.doi.org/10.2223/jped.148.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

14

Ringel, Marc, und Paul Rousseau. „Constipation“. Postgraduate Medicine 83, Nr. 4 (März 1988): 374–75. http://dx.doi.org/10.1080/00325481.1988.11700212.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

15

Hing, Michael. „Constipation“. Medical Journal of Australia 155, Nr. 2 (Juli 1991): 105–6. http://dx.doi.org/10.5694/j.1326-5377.1991.tb142137.x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

16

Mertz, Howard R. „Constipation“. Current Opinion in Gastroenterology 13, Nr. 1 (Januar 1997): 28–33. http://dx.doi.org/10.1097/00001574-199701000-00006.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

17

Imershein, Norma, und Elizabeth Linnehan. „Constipation“. Journal of Nutrition For the Elderly 19, Nr. 3 (19.06.2000): 49–54. http://dx.doi.org/10.1300/j052v19n03_04.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

18

Hull, Amy, und William Whitehead. „Constipation“. Obstetrics & Gynecology 109, Nr. 4 (April 2007): 985–89. http://dx.doi.org/10.1097/01.aog.0000259314.82648.ec.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

19

Smith, Leah L. S. „Constipation“. Clinical Pediatrics 46, Nr. 1 (Januar 2007): 83–85. http://dx.doi.org/10.1177/0009922806294285.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

20

Schmidt, Fernanda Mateus Queiroz, Vera Lúcia Conceição de Gouveia Santos, Rita de Cássia Domansky und José Marcio Jorge Neves. „Constipation“. Gastroenterology Nursing 39, Nr. 3 (2016): 204–11. http://dx.doi.org/10.1097/sga.0000000000000224.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

21

Wald, Arnold. „Constipation“. Current Opinion in Gastroenterology 31, Nr. 1 (Januar 2015): 45–49. http://dx.doi.org/10.1097/mog.0000000000000137.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

22

Winney, Jane. „Constipation“. Nursing Older People 10, Nr. 4 (01.08.1998): 26–31. http://dx.doi.org/10.7748/nop.10.4.26.s15.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

23

Kamm, Michael A. „Constipation“. Medicine 31, Nr. 2 (Februar 2003): 52–55. http://dx.doi.org/10.1383/medc.31.2.52.28608.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

24

Heaton, K. W. „Constipation“. Gut 36, Nr. 3 (01.03.1995): 476. http://dx.doi.org/10.1136/gut.36.3.476-a.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

25

Fisher, Pam. „Constipation“. Practice Nursing 11, Nr. 17 (Dezember 2000): 29–33. http://dx.doi.org/10.12968/pnur.2000.11.17.4466.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

26

Davison, Deborah. „Constipation“. Clinical Journal of Oncology Nursing 10, Nr. 1 (01.02.2006): 112–13. http://dx.doi.org/10.1188/06.cjon.112-113.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

27

Rao, Satish S. C. „Constipation:“. Gastroenterology Clinics of North America 32, Nr. 2 (Juni 2003): 659–83. http://dx.doi.org/10.1016/s0889-8553(03)00026-8.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

28

Lucak, Susan. „Constipation“. Gastrointestinal Endoscopy 42, Nr. 3 (September 1995): 285. http://dx.doi.org/10.1016/s0016-5107(95)70122-2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

29

Wald, Arnold. „CONSTIPATION“. Medical Clinics of North America 84, Nr. 5 (September 2000): 1231–46. http://dx.doi.org/10.1016/s0025-7125(05)70284-4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

30

Krinsky, Daniel L. „Constipation“. Pharmacy Today 26, Nr. 4 (April 2020): 15. http://dx.doi.org/10.1016/j.ptdy.2020.03.005.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

31

Borum, Marie L. „Constipation“. Primary Care: Clinics in Office Practice 28, Nr. 3 (September 2001): 577–90. http://dx.doi.org/10.1016/s0095-4543(05)70054-3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

32

Pemberton, John H. „Constipation“. Gastroenterology 109, Nr. 1 (Juli 1995): 329–30. http://dx.doi.org/10.1016/0016-5085(95)90307-0.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

33

Deepak, Parakkal, und Eli D. Ehrenpreis. „Constipation“. Disease-a-Month 57, Nr. 9 (September 2011): 511–17. http://dx.doi.org/10.1016/j.disamonth.2011.05.006.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

34

Lu, Peter L., und Hayat M. Mousa. „Constipation“. Gastroenterology Clinics of North America 47, Nr. 4 (Dezember 2018): 845–62. http://dx.doi.org/10.1016/j.gtc.2018.07.009.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

35

Winney, Jane. „Constipation“. Primary Health Care 8, Nr. 1 (01.02.1998): 31–37. http://dx.doi.org/10.7748/phc.8.1.31.s16.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

36

Costilla, Vanessa C., und Amy E. Foxx-Orenstein. „Constipation“. Clinics in Geriatric Medicine 30, Nr. 1 (Februar 2014): 107–15. http://dx.doi.org/10.1016/j.cger.2013.10.001.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

37

Clayden, G. S., und U. Agnarsson. „Constipation“. Current Paediatrics 1, Nr. 1 (März 1991): 8–12. http://dx.doi.org/10.1016/0957-5839(91)90036-d.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

38

Bharucha, Adil E. „Constipation“. Best Practice & Research Clinical Gastroenterology 21, Nr. 4 (August 2007): 709–31. http://dx.doi.org/10.1016/j.bpg.2007.07.001.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

39

Wald, Arnold. „Constipation“. JAMA 315, Nr. 2 (12.01.2016): 185. http://dx.doi.org/10.1001/jama.2015.16994.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

40

Wald, Arnold. „Constipation“. JAMA 315, Nr. 2 (12.01.2016): 214. http://dx.doi.org/10.1001/jama.2015.17991.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

41

Castle, Steven C. „Constipation“. Archives of Internal Medicine 147, Nr. 10 (01.10.1987): 1702. http://dx.doi.org/10.1001/archinte.1987.00370100016003.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

42

Sugerman, Deborah Tolmach. „Constipation“. JAMA 310, Nr. 13 (02.10.2013): 1416. http://dx.doi.org/10.1001/jama.2013.278592.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

43

Adams, Moses D., Taoheed K. Muftaudeen und Oluremi A. Saliu. „Polyphenol-rich extract of <I>Digitaria exilis</i> (Kippist) grain lowers gastrointestinal dysmotility and enhanced colonic peristalsis in rifaximin-induced constipated rat“. Nigerian Journal of Biochemistry and Molecular Biology 38, Nr. 3 (27.11.2023): 131–38. http://dx.doi.org/10.4314/njbmb.v38i3.4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Annotation:

Digitaria exilis grains rich in polyphenol have been speculated among some traditional practitioners of Northern Nigeria to aid in treating constipation. Hence, this study aims at assessing the anti-constipation property of polyphenol-rich extract of Digitaria exilis grains (PREDEG) in rifaximin-induced constipated rat. Thirty (30) Wistar rats of both sexes (143.84 ± 2.62 g) were assigned into 6 categories, A to F, of 5 rats each. Category A (control) received 0.4 ml of saline. Constipations were induced in categories B to F by oraladministration of rifaximin (2 mg/kg in saline for 48 h) and treated respectively with saline, glycerine (reference drug at 40 mg/kg), 50, 150 and 250 mg/kg of PREDEG (extracted via standard methods). All the treatments were given orally for 6 days using oral device. Rifaximin-induced constipation significantly (p < 0.05) decreases the feed and water intake, faecal quality, bodyweight and gastrointestinal flow proportion. All these alterations were attenuated dose-dependently, when co-treated with PREDEG and highest activity recorded at 250 mg/kg compared to reference drug. The data present polyphenol-rich extract of D. exilis grains as a potent anti-constipation agent and may act probably by lowering gastrointestinal dysmotility. This validates its traditional use in the treatment of constipation mostly in the Northern part of Nigeria.

44

Яницкая und M. Yanitskaya. „The Types of the Colon Revealed by Hydrocolonic Echography at Chronic Constipation in Children“. Journal of New Medical Technologies 20, Nr. 4 (20.12.2013): 31–37. http://dx.doi.org/10.12737/2722.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Annotation:

Retrospective cross research of results of a hydrocolonic echography (HCE) in 263 children with a constipations aged from 14 days till 17 years is carried out. The obtained data correlated to clinical manifestations. Seven types of echographic picture of the colon were revealed. The first four types corresponded to clinical forms of a functional constipations: compensated, subcompen-sated (dolihocolon) and decompensation (dolihomegacolon and megarectum), two types reflected features of fixing (Payr´s illness) or function of the colon (spastic colitis), and also type, characteristic for Hirschsprung´s disease. Secondary changes due to constipation are identified: thickening and "lamination" of a wall of a gut, lengthening (additional loops of the colon), dilatation of the lumen, smoothness or absence of the haustra, decrease in activity of a peristalsis, incomplete emptying of the colon, incontinence. Secondary changes didn´t depend on the constipation reason, and were a consequence of violation of depletion of the colon.

45

Saha, Sudip, Kallol Bose, Kallol Das, Dhrubojyoti Mridha, Ira Das und Piyasi Mondal. „Pattern of Constipation and Response to Polyethylene Glycol in Children“. Journal of Nepal Paediatric Society 36, Nr. 3 (16.04.2017): 263–67. http://dx.doi.org/10.3126/jnps.v36i3.15726.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Annotation:

Introduction: Constipation is a common problem in children with worldwide prevalence between 0.7% and 29.6%.Materials and Methods: Total number of children was 232 out of which 16 were discarded due to loss in follow up. Inclusion criteria: Any child aged one month to ten years presenting with constipation. We used NASPGHAN definition of constipation. Exclusion criteria: Critically sick and hemodynamically unstable patients were excluded from the study. Data were collected for age, sex, duration of constipation, symptoms and signs such as stool frequency, stool consistency, pain during defecation, presence of blood in stool, fecal and urinary incontinence, and presence of fecal impaction or an abdominal mass. Clinical evaluation (history and physical examination) of all patients was done by the same physician to avoid bias in clinical finding. Polyethylene glycol (PEG) was tried in all patients in a dose of 0.3 to 2.1g/kg. Response was defined as passage of at least one semisolid stool without discomfort with use of PEG for at least 4 weeks.Results: In our prospective study done on 232 patients with constipation over three year period (dividing patient’s into1month to 5months, 6months to 5year and 6 years to 10 years) revealed that constipation is mostly prevalent in 6 months to 5 year age group with slight male preponderance. Most of them had symptom onset after six months of age. Commonest symptom was hard stool in general (79.6%) but prevalence of pain abdomen increases with age and peaks in above five year group. Commonest sign is palpable fecal mass. Complications-urinary dysfunction, fecal incontinence, fissure are common in older age group. Functional constipation was the commonest cause (96.2%). Hirschprung disease was diagnosed in 1.4%. Polyethylene glycol shows good response in above 6 months of age groups.Conclusion: Functional constipationis the commonest cause of constipation. Mostly affected group is six months to five years. Polyethelene Glycol is an effective treatment especially after six months. J Nepal Paediatr Soc 2016;36(3):263-267.

46

Rajindrajith, Shaman, Niranga M. Devanarayana und Marc A. Benninga. „Constipation and Constipation-predominant Irritable Bowel Syndrome“. Journal of Pediatric Gastroenterology and Nutrition 64, Nr. 5 (Mai 2017): 679–84. http://dx.doi.org/10.1097/mpg.0000000000001332.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

47

Blight, Kathleen. „Understanding constipation“. Nursing Standard 15, Nr. 26 (14.03.2001): 26. http://dx.doi.org/10.7748/ns.15.26.26.s42.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

48

Ansell, Serena. „Constipation care“. Nursing Standard 17, Nr. 33 (30.04.2003): 26–27. http://dx.doi.org/10.7748/ns.17.33.26.s37.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

49

Meek, Patrick D., und Michael R. Brodeur. „Constipation/diarrhea“. Xiangya Medicine 1 (18.08.2016): 24. http://dx.doi.org/10.21037/xym.2016.08.08.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

50

Lembo, Anthony, und Michael Camilleri. „Chronic Constipation“. New England Journal of Medicine 349, Nr. 14 (02.10.2003): 1360–68. http://dx.doi.org/10.1056/nejmra020995.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Zeitschriftenartikel zum Thema „Constipation“

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an